Literature DB >> 31444275

Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1.

Dana V Rizk1, Manish K Saha2, Stacy Hall3, Lea Novak4, Rhubell Brown3, Zhi-Qiang Huang3, Huma Fatima4, Bruce A Julian2,3, Jan Novak5.   

Abstract

BACKGROUND: IgA nephropathy (IgAN) is the leading primary GN worldwide. The disease is thought to result from glomerular deposition of circulating immune complexes of IgG bound to galactose-deficient IgA1 (Gd-IgA1). However, routine immunofluorescence microscopy fails to detect IgG in many kidney biopsies from patients with IgAN and the specificity of IgG in immunodeposits has not been tested.
METHODS: We used remnant frozen kidney-biopsy specimens from 34 patients with IgAN; 14 were IgG-positive and 20 were IgG-negative by routine immunofluorescence microscopy. Six patients with primary membranous nephropathy (MN) and eight with lupus nephritis (LN) served as controls. IgG in the kidney tissue was extracted and its amount determined by ELISA. IgG molecular integrity was assessed by SDS-PAGE immunoblotting. Antigenic specificity of extracted IgG was determined by ELISA using phospholipase A2 receptor (PLA2R) or Gd-IgA1 as antigen. In addition, ten other IgAN cases, six IgG-positive and four IgG-negative by routine immunofluorescence, were used for colocalization studies by confocal microscopy.
RESULTS: IgG extracted from MN but not IgAN immunodeposits reacted with PLA2R. Conversely, IgG extracted from IgAN but not MN or LN immunodeposits reacted with Gd-IgA1. Even IgAN kidney-biopsy specimens without IgG by routine immunofluorescence microscopy had IgG specific for Gd-IgA1. Confocal microscopy confirmed the presence of IgG in the IgAN biopsies with colocalization of glomerular IgA and IgG.
CONCLUSIONS: These results reveal for the first time that IgAN kidney biopsies, with or without IgG by routine immunofluorescence, contain Gd-IgA1-specific IgG autoantibodies. These findings support the importance of these autoantibodies in the pathogenesis of IgAN.
Copyright © 2019 by the American Society of Nephrology.

Entities:  

Keywords:  IgA nephropathy; autoantibody; biomarker; immunodeposits

Mesh:

Substances:

Year:  2019        PMID: 31444275      PMCID: PMC6779349          DOI: 10.1681/ASN.2018111156

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  14 in total

1.  Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford classification patient cohort.

Authors:  Shubha S Bellur; Stéphan Troyanov; H Terence Cook; Ian S D Roberts
Journal:  Nephrol Dial Transplant       Date:  2011-01-27       Impact factor: 5.992

2.  Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity.

Authors:  Hitoshi Suzuki; Run Fan; Zhixin Zhang; Rhubell Brown; Stacy Hall; Bruce A Julian; W Winn Chatham; Yusuke Suzuki; Robert J Wyatt; Zina Moldoveanu; Jeannette Y Lee; James Robinson; Milan Tomana; Yasuhiko Tomino; Jiri Mestecky; Jan Novak
Journal:  J Clin Invest       Date:  2009-05-26       Impact factor: 14.808

Review 3.  IgA nephropathy.

Authors:  Robert J Wyatt; Bruce A Julian
Journal:  N Engl J Med       Date:  2013-06-20       Impact factor: 91.245

4.  Glomerular IgG deposition predicts renal outcome in patients with IgA nephropathy.

Authors:  Dong Ho Shin; Beom Jin Lim; In Mi Han; Seung Gyu Han; Young Eun Kwon; Kyoung Sook Park; Mi Jung Lee; Hyung Jung Oh; Jung Tak Park; Seung Hyeok Han; Shin-Wook Kang; Tae-Hyun Yoo
Journal:  Mod Pathol       Date:  2016-04-22       Impact factor: 7.842

Review 5.  The pathophysiology of IgA nephropathy.

Authors:  Hitoshi Suzuki; Krzysztof Kiryluk; Jan Novak; Zina Moldoveanu; Andrew B Herr; Matthew B Renfrow; Robert J Wyatt; Francesco Scolari; Jiri Mestecky; Ali G Gharavi; Bruce A Julian
Journal:  J Am Soc Nephrol       Date:  2011-09-23       Impact factor: 10.121

6.  [Intercapillary deposits of IgA-IgG].

Authors:  J Berger; N Hinglais
Journal:  J Urol Nephrol (Paris)       Date:  1968-09

7.  An evaluation of elution techniques in the study of immune complex glomerulonephritis.

Authors:  A J Woodroffe; C B Wilson
Journal:  J Immunol       Date:  1977-05       Impact factor: 5.422

8.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.

Authors:  Laurence H Beck; Ramon G B Bonegio; Gérard Lambeau; David M Beck; David W Powell; Timothy D Cummins; Jon B Klein; David J Salant
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

9.  Chronicity index and mesangial IgG deposition are risk factors for hypertension and renal failure in early IgA nephropathy.

Authors:  C Nieuwhof; M Kruytzer; P Frederiks; P J van Breda Vriesman
Journal:  Am J Kidney Dis       Date:  1998-06       Impact factor: 8.860

10.  Clinical significance of IgG deposition in the glomerular mesangial area in patients with IgA nephropathy.

Authors:  Yukihiro Wada; Hiroaki Ogata; Yui Takeshige; Akiko Takeshima; Noriyo Yoshida; Masahiro Yamamoto; Hidetoshi Ito; Eriko Kinugasa
Journal:  Clin Exp Nephrol       Date:  2012-07-03       Impact factor: 2.801

View more
  28 in total

1.  Crucial Role of AIM/CD5L in the Development of Glomerular Inflammation in IgA Nephropathy.

Authors:  Akiko Takahata; Satoko Arai; Emiri Hiramoto; Kento Kitada; Rina Kato; Yuko Makita; Hitoshi Suzuki; Junichiro Nakata; Kimi Araki; Toru Miyazaki; Yusuke Suzuki
Journal:  J Am Soc Nephrol       Date:  2020-07-01       Impact factor: 10.121

Review 2.  Cytokines and Production of Aberrantly O-Glycosylated IgA1, the Main Autoantigen in IgA Nephropathy.

Authors:  Taylor Person; R Glenn King; Dana V Rizk; Jan Novak; Todd J Green; Colin Reily
Journal:  J Interferon Cytokine Res       Date:  2022-07-06       Impact factor: 3.657

3.  TNF-α-mediated podocyte injury via the apoptotic death receptor pathway in a mouse model of IgA nephropathy.

Authors:  Qiang Wan; Jiabao Zhou; Yansheng Wu; Liqiang Shi; Weiwei Liu; Jiaoying Ou; Jiandong Gao
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

4.  Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy.

Authors:  Zina Moldoveanu; Hitoshi Suzuki; Colin Reily; Kenji Satake; Lea Novak; Nuo Xu; Zhi-Qiang Huang; Barbora Knoppova; Atlas Khan; Stacy Hall; Hiroyuki Yanagawa; Rhubell Brown; Colleen J Winstead; Darrell B O'Quinn; Amy Weinmann; Ali G Gharavi; Krzysztof Kiryluk; Bruce A Julian; Casey T Weaver; Yusuke Suzuki; Jan Novak
Journal:  J Autoimmun       Date:  2021-01-25       Impact factor: 7.094

Review 5.  IgA Nephropathy: An Interesting Autoimmune Kidney Disease.

Authors:  Arun Rajasekaran; Bruce A Julian; Dana V Rizk
Journal:  Am J Med Sci       Date:  2020-10-08       Impact factor: 2.378

6.  Quantitative assessment of successive carbohydrate additions to the clustered O-glycosylation sites of IgA1 by glycosyltransferases.

Authors:  Tyler J Stewart; Kazuo Takahashi; Nuo Xu; Amol Prakash; Rhubell Brown; Milan Raska; Matthew B Renfrow; Jan Novak
Journal:  Glycobiology       Date:  2021-06-03       Impact factor: 4.313

Review 7.  Treatment strategy with multidrug therapy and tonsillectomy pulse therapy for childhood-onset severe IgA nephropathy.

Authors:  Yukihiko Kawasaki
Journal:  Clin Exp Nephrol       Date:  2022-02-04       Impact factor: 2.801

Review 8.  IgA glycosylation and immune complex formation in IgAN.

Authors:  Hitoshi Suzuki; Jan Novak
Journal:  Semin Immunopathol       Date:  2021-09-27       Impact factor: 9.623

Review 9.  IgA vasculitis with nephritis: update of pathogenesis with clinical implications.

Authors:  M Colleen Hastings; Dana V Rizk; Krzysztof Kiryluk; Raoul Nelson; Rima S Zahr; Jan Novak; Robert J Wyatt
Journal:  Pediatr Nephrol       Date:  2021-04-05       Impact factor: 3.651

10.  Low serum IgG4 level: a potential diagnostic biomarker for IgA nephropathy.

Authors:  Xinyu Tian; Zhuan Cui; Song Wang; Yuejuan Pan; A Lata; Xinxin Chen; Xiaoxiao Wang; Xiaoyan Qiu; Zhenling Deng; Yue Wang
Journal:  Ann Transl Med       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.